Morphic Therapeutic
Morphic Therapeutic develops and commercializes oral integrin drugs for the treatment of immunological, fibrotic and neoplastic diseases.
Business Model:
Revenue: $74.2M
Employees: 51-200
Industries / Tags:
Detailed Morphic Therapeutic Information
Geographic Data
Address: 35 Gatehouse Drive A-2
City: Waltham
State: MA
Zip: 02451
Country: US
Financial Info
Stage:
series b
Raised Last:
$80M
Raised Total:$135M
Social
Metrics
3,408,300Website Global Rank
4,262Website Monthly Traffic
Twitter Followers
Description
Morphic Therapeutic develops and commercializes oral integrin drugs for the treatment of immunological, fibrotic and neoplastic diseases.
Contact Phone:
+17819960955
Contact Email:
Morphic Therapeutic went public on 6/27/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/27/2019
IPO Valuation:
$429M
Ticker Symbol:
MORF
IPO Price:
$15/share
Amount Raised:
$90M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
